epiCervix
***Please contact customer service for the correct price.
Detection Target: The epicervix kit is designed for the accurate early detection of cervical cancer using the proprietary APDMA-next generation method, aiming to improve the accuracy and efficiency of cervical cancer screening.
Technology Overview:
- Proprietary Technology: The epicervix kit employs the proprietary APDMA-next generation method, an innovative DNA methylation analysis technology capable of efficiently identifying cervical cancer-related methylation markers.
- Early Detection: This technology is particularly suited for the early detection of cervical cancer, accurately identifying precancerous cells in the early stages of cancer development.
Contact Information:
- If you are interested in the epicervix Cervical Cancer Early Detection Kit or wish to learn more details, please contact our customer service team for further information and accurate pricing.
Return policy
• There is no refund once the products are sold.
Disclaimer
• The Epiaging test is not intended to be health information or medical data or to be used to screen, diagnose, treat, prevent or assess the risk of any disease or condition.
• The epiaging service is an epigenetic age determination based on the assessment of DNA methylation in your DNA.
• We are not collecting genetic data.
• This service has not been cleared or approved by U. S. Food and Drug Administration.